Nephrocare Health Services Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services, has entered into an Asset Transfer Agreement (ATA) dated 09 June 2026 with Amica Healthcare System Corporation for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines, for a total consideration of PhP 32,640,000, subject to the terms and conditions set out therein.

The agreement is to acquire identified assets related to a dialysis centre in Quezon City, Philippines.

The acquisition pertains to a dialysis facility located at Duyan-Duyan, Project 3, Quezon City, and is being undertaken for a total consideration of PHP 30 million.

The company said the transaction is aimed at expanding its dialysis care footprint in the Philippines and will be executed in accordance with the terms and conditions of the agreement.

Nephrocare clarified that the seller is not related to the company, its promoters, or promoter group entities. The transaction does not qualify as a related-party transaction and does not involve any special rights or share issuance arrangements.

Nephrocare Health Services provides end-to-end dialysis care through a wide network of clinics across India and select international markets.

The compnay?s consolidated net profit rose 22.1% to Rs 30.37 crore on 21.2% increase in revenue from operations to Rs 265.62 crore in Q4 FY26 over Q4 FY25.

Powered by Capital Market - Live News

Net profit of Nephrocare Health Services rose 22.12% to Rs 30.37 crore in the quarter ended March 2026 as against Rs 24.87 crore during the previous quarter ended March 2025. Sales rose 21.18% to Rs 265.62 crore in the quarter ended March 2026 as against Rs 219.19 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.52% to Rs 76.84 crore in the year ended March 2026 as against Rs 67.10 crore during the previous year ended March 2025. Sales rose 32.16% to Rs 998.85 crore in the year ended March 2026 as against Rs 755.81 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Nephrocare Health Services will hold a meeting of the Board of Directors of the Company on 19 May 2026.